Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/07/2009EP2106787A2 Biodegradable block copolymeric compositions for drug delivery
10/07/2009EP2106786A1 Pharmaceutical preparation comprising permethylated cyclodextrin
10/07/2009EP2106785A1 Device and method for treating urinary incontinence in females
10/07/2009EP2106401A2 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
10/07/2009EP2106400A2 Benzoquinazole derivatives
10/07/2009EP2106399A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/07/2009EP2106398A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
10/07/2009EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/07/2009EP2106260A1 Insulin sensitisers and methods of treatment
10/07/2009EP2106259A2 Use of compositions comprising at least one alfa3 beta4 nachr antagonist such as mecamylamine in the treatment of gastrointestinal disorders
10/07/2009EP2106258A2 Non-steroid antiphlogistics against coughing
10/07/2009EP2106247A1 Prevention and treatment of androgen-deprivation induced skeletal-related event (sre)
10/07/2009EP2106212A2 Nuclear receptor binding agents
10/07/2009EP1954264B1 Process for the manufacture of epoxybutanol intermediates
10/07/2009EP1917014B1 Neurorestoration with r(+) pramipexole
10/07/2009EP1915375B1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/07/2009EP1898904B1 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
10/07/2009EP1896006B1 A manufacturing method for entacapone-containing granules for oral dosage forms
10/07/2009EP1874285B1 Complementary compositions to reduce blood glucose levels and treat diabetes
10/07/2009EP1756087B1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
10/07/2009EP1719509B1 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiogenesisdependent diseases such as cancer and psoriasis
10/07/2009EP1709027B1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/07/2009EP1682147B1 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
10/07/2009EP1667741B1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone
10/07/2009EP1655032B1 USE OF THE P2X7 ANTAGONISTS o-ATP OR BBG FOR THE TREATMENT OF THE NEURODEGENERATIVE PHASE OF MULTIPLE SCLEROSIS
10/07/2009EP1654002B1 Compositions for delivery of therapeutics into the eyes and methods for making and using the same
10/07/2009EP1650182B1 Branched carboxylic acid compound and use thereof
10/07/2009EP1648413B1 Pharmaceutical compositions of short-acting sedative hypnotic agent
10/07/2009EP1537113B1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/07/2009EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009EP1509227B1 A buffered, liquid nicotine composition for pulmonary administration
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1501493B1 Use of epa and dha in secondary prevention of strokes
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1421112B1 Novel serine protease
10/07/2009EP1406682B1 Drug delivery devices
10/07/2009EP1392389B1 Microprojection array having a beneficial agent containing coating
10/07/2009EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009EP1339413B1 Compositions comprising complexes of phosphate derivatives of tocopherol
10/07/2009EP1311249B1 Set of transdermal therapeutic systems
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009EP1292347B1 Drug delivery apparatus
10/07/2009EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/07/2009EP1235595B8 Integrin-mediated drug targeting
10/07/2009EP1191099B1 Novel polypeptide and dna thereof
10/07/2009EP1187917B1 Cd44 splice variant associated with rheumatoid arthritis
10/07/2009EP1104301B1 Treatment of psychosis or neuropsychiatric symptoms associated with Alzheimer's Disease
10/07/2009EP1007077B1 Glutathione for the treatment of influenza infection
10/07/2009EP1000043B1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
10/07/2009EP0907735B2 Modulators of tissue regeneration
10/07/2009EP0907730B1 Haemopoietin receptor and genetic sequences encoding same
10/07/2009EP0861247B1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
10/07/2009EP0572557B1 Use of topotecan in the manufacture of a medicament for use in the treatment of ovarian cancer
10/07/2009EP0560816B1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
10/07/2009CN201320299Y Nifuratel coated tablet
10/07/2009CN101553578A glmS riboswitches, structure-based compound design with glmS riboswitches, and methods and compositions for use of and with glmS riboswitches
10/07/2009CN101553497A Anti-tumor compounds for inhibiting cancer growth
10/07/2009CN101553493A Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
10/07/2009CN101553492A RAF inhibitor compounds and methods of use thereof
10/07/2009CN101553491A Quinoxaline derivative
10/07/2009CN101553490A Bicyclic triazoles as protein kinase modulators
10/07/2009CN101553489A 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
10/07/2009CN101553488A Hypertension-ameliorating agent
10/07/2009CN101553486A Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
10/07/2009CN101553484A Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
10/07/2009CN101553483A 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
10/07/2009CN101553480A Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
10/07/2009CN101553478A Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity
10/07/2009CN101553476A Mitotic kinesin inhibitors and methods of use thereof
10/07/2009CN101553475A Hydroxamates as inhibitors of histone deacetylase
10/07/2009CN101553474A Imidazolone and imidazolidinone derivatives as 11b-HSD1 inhibitors for diabetes
10/07/2009CN101553473A Substituted pyrazoles, compositions containing these, method of production and use
10/07/2009CN101553472A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
10/07/2009CN101553471A 抗菌喹啉衍生物 Antibacterial quinoline derivatives
10/07/2009CN101553470A Antibacterial quinoline derivatives
10/07/2009CN101553469A Carboxylic acid derivative
10/07/2009CN101553467A 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands
10/07/2009CN101553466A New crystalline forms
10/07/2009CN101553456A Crystalline potassium salt of lipoxin A4 analogs
10/07/2009CN101553261A Glucan preparations
10/07/2009CN101553258A Stable parenteral formulation containing a RSV inhibitor of a benzodiazepine structure
10/07/2009CN101553253A Combination of ZD6474 and bevacizumab for cancer therapy
10/07/2009CN101553246A Protein matrix vaccines and methods of making and administering such vaccines
10/07/2009CN101553238A Compositions for providing hepatoprotective effect
10/07/2009CN101553237A Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
10/07/2009CN101553236A Compounds and methods for modulating expression of GCCR
10/07/2009CN101553235A Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye
10/07/2009CN101553234A Use of estradiol valerate or 17ss-estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido
10/07/2009CN101553233A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/07/2009CN101553232A Kinase inhibitors useful for the treatment of proliferative diseases
10/07/2009CN101553231A Modulators of muscarinic receptors
10/07/2009CN101553230A Controlled release formulations and associated methods
10/07/2009CN101553229A 1,2,3,4-tetrahydroisoquinoline derivatives having effects of preventing and treating degenerative and inflammatory diseases
10/07/2009CN101553228A Treatment of fibrosing disorders
10/07/2009CN101553227A Use of Epothilones in the treatment of osteoporosis and related diseases
10/07/2009CN101553226A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/07/2009CN101553224A Novel imidazothiazoles and imidazoxazoles
10/07/2009CN101553223A Combination of an HDAC inhibitor and an antimetabolite
10/07/2009CN101553222A Combination drug
1 ... 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 ... 7860